Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pei N Ding"'
Autor:
Pei N. Ding, Therese Becker, Victoria Bray, Wei Chua, Yafeng Ma, Bo Xu, David Lynch, Paul de Souza, Tara Roberts
Publikováno v:
Thoracic Cancer, Vol 10, Iss 10, Pp 1879-1884 (2019)
Background Gene mutation analysis from plasma circulating tumor DNA (ctDNA) can provide timely information regarding the mechanism of resistance that could translate to personalised treatment. We compared concordance rate of next generation sequencin
Externí odkaz:
https://doaj.org/article/41ee61caf787449a842cbc2450a62f97
Autor:
Malinda Itchins, Helen Westman, Stephen Clarke, Chee Khoon Lee, Steven Kao, Thomas John, Jose Luis Leal, Tara L. Roberts, Bo Gao, Paul de Souza, Victoria J Bray, Pei N Ding, Nicole J. Caixeiro, Therese M. Becker, Prunella Blinman, Wei Chua
Publikováno v:
Transl Lung Cancer Res
Background Approximately half of all patients with advanced EGFR-mutant NSCLC will develop acquired resistance to first or second-generation EGFR tyrosine kinase inhibitors (EGFR-TKIs) with a T790M mutation. In the AURA3 trial, patients with a T790M
Autor:
Nicole J. Caixeiro, Wei Chua, P. de Souza, Joseph W. Po, David A. Lynch, Victoria J Bray, Alison W S Luk, Therese M. Becker, Yafeng Ma, Tara L. Roberts, Pei N Ding
Publikováno v:
Lung Cancer. 134:187-193
To determine the predictive and prognostic roles of three blood-based biomarkers: circulating tumour DNA (ctDNA), circulating tumour cells (CTC) and carcinoembryonic antigen (CEA), in patients with advanced epidermal growth factor receptor-mutated (E
Autor:
Tara L. Roberts, Po Yee Yip, Joseph Descallar, Therese M. Becker, Victoria J Bray, Pei N Ding, Wei Chua
Publikováno v:
Internal Medicine Journal. 47:1405-1411
Background Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC) is a subgroup of oncogene addicted lung cancer that predicts response to tyrosine kinase inhibitors (TKI). However, there is variability in response and sur
Autor:
Pei N Ding, David A. Lynch, Tara J Roberts, Victoria J Bray, Yafeng F Ma, Wei Chua, Therese M. Becker, Paul de Souza, Daniel Burke
Publikováno v:
Journal of Molecular Biomarkers & Diagnosis.
Autor:
David A. Lynch, P. de Souza, Joseph W. Po, Nicole J. Caixeiro, Alison W S Luk, Tara L. Roberts, Wei Chua, Yafeng Ma, Pei N Ding, Victoria J Bray, Therese M. Becker
Publikováno v:
Annals of Oncology. 29:viii660
Autor:
Daniel T Dransfield, Alison W S Luk, Pei N Ding, Francis P Young, Bavanthi Balakrishnar, Therese M. Becker, Yafeng Ma, Wei Chua, Paul de Souza
Publikováno v:
International Journal of Molecular Sciences; Volume 18; Issue 5; Pages: 1047
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Circulating tumour cells (CTCs) are an emerging resource for monitoring cancer biomarkers. New technologies for CTC isolation and biomarker detection are increasingly sensitive, however, the ideal blood storage conditions to preserve CTC-specific mRN